This paper explores the opportunities to improve the R&D process. It proposes new technologies will enable the adoption of virtual R&D; and by operating in a more connected world, the industry in collaboration with researchers, governments, healthcare payers and providers, can address the changing needs of society more effectively.
In 2005, 10 years after America’s farmers began planting bio- technology-derived crops, the National Center for Food and Agricultural Policy announced that the 1 billionth biotech acre had been planted. In the two years since, American farmers continue to plant crops produced by biotechnology as scientists further develop and validate the safety EXECUTIVE of this science, and consumers continue ...
Medical devices developed for human application are used for diagnostic or treatment purposes. They may either be an instrument, an apparatus or a material. Moreover, these devices can be used for daily patient care as well as for medical scientific purposes. Researchers in charge to develop new medical devices are faced with the complex task of making a medical device safe for human use. This ...
IBM has partnered with Harvard University researchers on a new WCG project to discover organic materials that have the potential to create a more efficient and lower-cost solar cell. If this research proves fruitful, it has the potential to make solar energy much more cost-competitive with fossil fuels and other power generation methodologies. The project not only has the potential of solving ...
Metabolic balance among different classes of fatty acids has been recognized as an important factor in maintaining optimal health. As a result, fatty acid analysis is becoming an increasingly important tool in the study of aging and age related diseases. People with unhealthy diets, especially diets with unbalanced fat intake, are more likely to develop age related diseases at an earlier age than ...
The last decade has seen rapid technological progress but with increasing demands for safe and efficacious drugs, technological solutions that reduce the barriers to clinical success will be of more interest than those that simply shift the bottlenecks and necessitate new compromises in the discovery and development process. Find out which technologies are at the forefront of clinical success.
Company descriptions and contact
information are quoted
from the company's website or other promotional information. JAZ'D is not responsible for
the accuracy
of this information. Unless specifically noted, JAZ'D is not sponsored by, affiliated with
or otherwise
connected with any of the listed companies.
